about
Decreased hematocrit-to-viscosity ratio and increased lactate dehydrogenase level in patients with sickle cell anemia and recurrent leg ulcersNormal muscle oxygen consumption and fatigability in sickle cell patients despite reduced microvascular oxygenation and hemorheological abnormalities.Male gender, increased blood viscosity, body mass index and triglyceride levels are independently associated with systemic relative hypertension in sickle cell anemia.Hematological and hemorheological determinants of the six-minute walk test performance in children with sickle cell anemia.Acute moderate exercise does not further alter the autonomic nervous system activity in patients with sickle cell anemia.High red blood cell nitric oxide synthase activation is not associated with improved vascular function and red blood cell deformability in sickle cell anaemia.Blood thixotropy in patients with sickle cell anaemia: role of haematocrit and red blood cell rheological properties.Uncommon Posterior Reversible Encephalopathy Syndrome in a Sickle-Cell Patient.Effect of Age on Blood Rheology in Sickle Cell Anaemia and Sickle Cell Haemoglobin C Disease: A Cross-Sectional StudyMicro- and macrovascular function in children with sickle cell anaemia and sickle cell haemoglobin C disease.Hemorheological risk factors of acute chest syndrome and painful vaso-occlusive crisis in children with sickle cell disease.Hematopoietic colony formation from human growth factor-dependent TF1 cells and human cord blood myeloid progenitor cells depends on SHP2 phosphatase functionHematologic and hemorheological determinants of resting and exercise-induced hemoglobin oxygen desaturation in children with sickle cell diseaseRelationships between systemic vascular resistance, blood rheology and nitric oxide in children with sickle cell anemia or sickle cell-hemoglobin C disease.Severe proliferative retinopathy is associated with blood hyperviscosity in sickle cell hemoglobin-C disease but not in sickle cell anemiaDoes increased red blood cell deformability raise the risk for osteonecrosis in sickle cell anemia?Exacerbation of oxidative stress during sickle vaso-occlusive crisis is associated with decreased anti-band 3 autoantibodies rate and increased red blood cell-derived microparticle level: a prospective study.Red blood cell aggregation, aggregate strength and oxygen transport potential of blood are abnormal in both homozygous sickle cell anemia and sickle-hemoglobin C disease.Impaired blood rheology plays a role in the chronic disorders associated with sickle cell-hemoglobin C disease.Hydroxyurea treatment does not increase blood viscosity and improves red blood cell rheology in sickle cell anemia.Lactic response in sickle cell trait carriers in comparison with subjects with normal hemoglobin.Cord blood transplantation and the potential for gene therapy. Gene transduction using a recombinant adeno-associated viral vector.Association of adenylyl cyclase 6 rs3730070 polymorphism and hemolytic level in patients with sickle cell anemia.Impaired oxygen uptake efficiency slope and off-transient kinetics of pulmonary oxygen uptake in sickle cell anemia are associated with hemorheological abnormalities.Does higher red blood cell (RBC) lactate transporter activity explain impaired RBC deformability in sickle cell trait?Physical activity level is not a determinant of autonomic nervous system activity and clinical severity in children/adolescents with sickle cell anemia: A pilot study.Hemorheological alterations, decreased cerebral microvascular oxygenation and cerebral vasomotion compensation in sickle cell patients.Impact of eNOS polymorphisms on red blood cell aggregation in sickle cell disease.Red blood cell nitric oxide synthase activation is increased in patients with sickle cell hemoglobin C disease.Rheology of red blood cells in patients with HbC disease.Haemolysis and abnormal haemorheology in sickle cell anaemia.Alpha thalassemia protects sickle cell anemia patients from macro-albuminuria through its effects on red blood cell rheological properties.Is there a relationship between the hematocrit-to-viscosity ratio and microvascular oxygenation in brain and muscle?Increased blood viscosity and red blood cell aggregation in a patient with sickle cell anemia and smoldering myeloma.Delayed beneficial effect of acute exercise on red blood cell aggregate strength in patients with sickle cell anemia.Cardiorespiratory responses during three repeated incremental exercise tests in sickle cell trait carriers.Changes in autonomic nervous activity during vaso-occlusive crisis in patients with sickle cell anaemia.CAREST--Multilingual Regional Integration for Health Promotion and Research on Sickle Cell Disease and Thalassemia.Which side of the balance determines the frequency of vaso-occlusive crises in children with sickle cell anemia: Blood viscosity or microvascular dysfunction?Association between relative systemic hypertension and otologic disorders in patients with sickle cell-hemoglobin C disorder
P50
Q28534804-7635A22C-5651-4434-85B7-9F8CF77C5954Q34533957-CA35107B-CC8A-4210-ABA5-0A440E671A9FQ34778805-D86D108C-33F3-4C37-9EFF-10BAC6AAA3E7Q35023443-2B5A2B4B-5759-4213-949D-A03BB4360F34Q35150713-8E057B75-18EE-4F4C-AF85-70F0C9488436Q35333161-098D51D0-2D1B-4088-8FFF-1FA0033C09E7Q35515325-90991049-0E81-45E6-B7E3-52237E4A5F2EQ35866137-E06C3A34-8749-4B31-AAF5-119C787D0AECQ36063983-D0BAE145-0D71-4520-ACF0-D41ADB7FCC42Q36322373-39410049-9A2A-462A-9BA5-BFEBB4EE30AEQ36366564-53755813-A8ED-4E8C-AB0C-AF6EDBA91067Q36648071-1CB918EF-6DA1-4ADE-A6C6-2A14F4C3EF80Q36967104-BA371A70-0D78-45F4-A12D-AF9E0D02D14BQ37059393-C95F5CF1-0CFD-44F3-B2DD-69C819A6F18EQ37578486-5FB0B032-F7EF-4C06-B245-BF5DC358A609Q37705018-1CC58768-24BA-4A15-984D-EF86DBF10197Q39094303-F161F5DA-EEAD-434B-8096-A227CA0D457FQ41856645-15B95F2F-359F-4CF7-A2FF-CE70FF1A5B27Q42551534-ACCB04E1-CA1A-4F47-AB1B-C6CAD9DBF234Q42589186-6782F671-F37B-40BD-89BB-F55214B2860AQ44357463-9F99C069-92E4-4131-AD05-2F5BB63D099BQ45876292-92A0ACDC-4175-4B3C-9C8A-A6B5D9FBA73CQ46269033-D666A482-8E17-4F6D-A6DA-28B096D9CFC5Q46426430-763854E6-4B83-49B2-9533-1DB0222A7434Q46915462-64DBC724-7FB6-4A5F-B2E7-ED85D9AB1E65Q48038108-28D78CC2-99A4-485B-B951-44DCA05F2C49Q48402687-2420ACC1-F2A6-4020-B8F7-0F587B2D6FBCQ50441221-F51D2C72-C04E-40ED-A1B7-221BE9579D98Q50457346-37AE00F4-33D7-4C96-BC0C-0E9B3C765E49Q50458064-B1B55200-1BAC-418D-837C-210F927F00E6Q50477420-D20CDD0B-CD1A-45C9-9A18-303E1D14725BQ50486537-C4746DDA-875B-40D1-9FEB-776AD5E8BE60Q50490393-5770CFC0-01AB-4E21-8B49-595086D00BE6Q50504599-1910FF77-F8CE-4A9A-8C61-5ADE7899F782Q50515151-599426DC-8F25-4AD7-AD7E-98DF5760FF05Q50674849-CB14EAB6-D7B4-4679-84F9-EB44B818CB1EQ53138818-E2DF0347-078D-4FFD-9E79-86B75001BE29Q53768396-F3A14D31-2F78-419D-8796-21B0876E7491Q53808037-E020946B-A3B2-4B10-9ADA-2EB16497B81BQ57636140-15BD73B5-AC62-444A-BB66-0674D7A1AD3D
P50
description
researcher ORCID ID = 0000-0003-1339-6545
@en
wetenschapper
@nl
name
Maryse Etienne-Julan
@ast
Maryse Etienne-Julan
@en
Maryse Etienne-Julan
@es
Maryse Etienne-Julan
@nl
type
label
Maryse Etienne-Julan
@ast
Maryse Etienne-Julan
@en
Maryse Etienne-Julan
@es
Maryse Etienne-Julan
@nl
prefLabel
Maryse Etienne-Julan
@ast
Maryse Etienne-Julan
@en
Maryse Etienne-Julan
@es
Maryse Etienne-Julan
@nl
P106
P1153
6602709402
P31
P496
0000-0003-1339-6545